Abstract
Intermittent parathyroid hormone (PTH) administration increases bone formation and bone mass and is being used as a therapy for osteoporosis. By contrast, chronic hyperparathyroidism results in the metabolic bone disease osteitis fibrosa characterized by local bone resorption and peritrabecular bone marrow fibrosis in humans. The animal models that can mimic the paradoxical effects of PTH provide the basis for further study of the functions of this hormone in skeletal tissues. In both rats and mice, the anabolic effects of PTH on bone can be achieved by daily injections subcutaneously and the catabolic effects can be achieved by continuous infusion with osmotic pumps. This chapter offers detailed informa tion, such as the dosage and preparation of PTH, using the example of treatment of rats with PTH intermittently or continuously. High-quality, RT-PCR ready RNA is required for the analysis of gene expression. For the analysis of gene expression in bone, usually long bones are used for RNA extraction. Here we describe how to extract RNAs from the metaphyseal trabecular primary spongiosa of rat femur by a method based on two commercially available kits. This protocol can be used in other tissues with slight modification of the amount of reagent used according to the tissue size.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
1. Bauer, W., Aub, J., Albright, F. (1929) Studies in calcium phosphorus metabolism: study of bone trabeculae as ready available reserve supply of calcium. J Exp Med 49, 145–162.
2. Burr, D. B., Hirano, T., Turner, C. H., et al. (2000) Intermittently administered human parathy roid hormone (1–34) treatment increases intracortical bone turnover and porosity without reducing bone strength in the humerus of ovariectomized cynomolgus monkeys. J Bone Miner Res 16, 157–165.
3. Neer, R. M., Arnaud, C. D., Zanchetta, J. R., et al. (2001) Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. NEJM 344, 1434–1441.
4. Dempster, D. W., Cosman, F., Kurland, E. S., et al. (2001) Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study. J Bone Miner Res 16, 1846–1853.
5. Brommage, R., Hotchkiss, C. E., Lees, C. J., et al. (1999) Daily treatment with human recom-binant parathyroid hormone-(1–Y333334, for 1 year increases bone mass in ovariectomized monkeys. J Clin Endocrinol Metab 84, 3757–3763.
6. Onyia, J. E., Bidwell, J., Herring, J., et al. (1995) In vivo, human parathyroid hormone fragment (hPTH 1–34) transiently stimulates immediate early response gene expression, but not proliferation, in trabecular bone cells of young rats. Bone 17, 479–484.
Alzet Guide to Pump Use (Alzet).
Protocol for Sigma's TRI Reagent (Sigma).
RNase Mini Handbook (Qiagen).
10. Li, X. (2006) Parathyroid hormone's dual effects (anabolic versus catabolic) on osteoblast gene expression. Doctoral dissertation. University of Medicine and Dentistry of New Jersey, Newark, NJ.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Xin, L., Ling, Q., Nicola, C. (2008). In Vivo Parathyroid Hormone Treatments and RNA Isolation and Analysis. In: Westendorf, J.J. (eds) Osteoporosis. Methods In Molecular Biology™, vol 455. Humana Press. https://doi.org/10.1007/978-1-59745-104-8_5
Download citation
DOI: https://doi.org/10.1007/978-1-59745-104-8_5
Publisher Name: Humana Press
Print ISBN: 978-1-58829-828-7
Online ISBN: 978-1-59745-104-8
eBook Packages: Springer Protocols